Sofie Verbeke
Overview
Explore the profile of Sofie Verbeke including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
29
Citations
244
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Verghote F, Rammant E, Dirix P, Van Praet C, Berghen C, Junius S, et al.
Eur Urol Focus
. 2025 Feb;
PMID: 39971695
Background And Objective: Patients with muscle-invasive bladder cancer (MIBC) who develop a recurrence after radical cystectomy (RC) have poor outcomes. This study aims to evaluate the safety and efficacy of...
2.
De Maeseneer D, De Visschere P, Van den Broecke M, Delbare F, Villeirs G, Verbeke S, et al.
BMC Med Imaging
. 2024 Oct;
24(1):268.
PMID: 39375642
Background: Muscle invasive bladder cancer (MIBC) treatment combines systemic therapy and radical cystectomy (RC) or local (chemo-)radiotherapy. Response to systemic therapy is an important outcome predictor but is difficult to...
3.
Franco A, Tailly T, Berquin C, De Maeseneer D, Decruyenaere A, Verbeke S, et al.
Clin Genitourin Cancer
. 2024 Sep;
22(6):102202.
PMID: 39288545
Medullary sponge kidney (MSK) is an uncommon kidney malformation, characterized by cystic dilatation of the precalyceal papillary collecting ducts. Urography and computed tomography scan represent the gold standard to detect...
4.
Sutera P, Song Y, Shetty A, English K, Van der Eecken K, Guler O, et al.
Eur Urol Oncol
. 2024 Jun;
8(1):111-118.
PMID: 38862340
Background And Objective: Oligometastatic castration-sensitive prostate cancer (omCSPC) represents an early state in the progression of metastatic disease for which patients experience better outcomes in comparison to those with higher...
5.
Warner E, Van der Eecken K, Murtha A, Kwan E, Herberts C, Sipola J, et al.
Nat Cancer
. 2024 Jan;
5(1):114-130.
PMID: 38177459
De novo metastatic prostate cancer is highly aggressive, but the paucity of routinely collected tissue has hindered genomic stratification and precision oncology. Here, we leveraged a rare study of surgical...
6.
Aerts J, Hendrickx S, Berquin C, Lumen N, Verbeke S, Villeirs G, et al.
Eur Urol Open Sci
. 2023 Oct;
56:39-46.
PMID: 37822515
Background: The Prostate Cancer Radiological Estimation of Change in Sequential Evaluation (PRECISE) score has been developed to standardise prostate magnetic resonance imaging (MRI) reporting in men on active surveillance (AS)...
7.
Pizurica M, Larmuseau M, Van der Eecken K, de Schaetzen van Brienen L, Carrillo-Perez F, Isphording S, et al.
Cancer Res
. 2023 Jun;
83(17):2970-2984.
PMID: 37352385
Significance: Deep learning models predicting TP53 mutations from whole slide images of prostate cancer capture histologic phenotypes associated with stromal composition, lymph node metastasis, and biochemical recurrence, indicating their potential...
8.
Sutera P, Song Y, Van der Eecken K, Shetty A, English K, Hodges T, et al.
Eur Urol
. 2023 May;
84(6):531-535.
PMID: 37173210
In metastatic castration-sensitive prostate cancer (mCSPC), disease volume plays an integral role in guiding treatment recommendations, including selection of docetaxel therapy, metastasis-directed therapy, and radiation to the prostate. Although there...
9.
Lambert E, Allaeys C, Berquin C, De Visschere P, Verbeke S, Vanneste B, et al.
Curr Oncol
. 2023 Mar;
30(3):3447-3460.
PMID: 36975474
Background: Retzius-sparing robot-assisted radical prostatectomy (RS-RARP) has been shown to lead to better outcomes regarding early continence compared to standard anterior RARP (SA-RARP). The goal of this study was to...
10.
Sutera P, Deek M, Van der Eecken K, Shetty A, Chang J, Hodges T, et al.
Int J Radiat Oncol Biol Phys
. 2023 Jan;
115(5):1095-1101.
PMID: 36708787
Purpose: WNT signaling is a cellular pathway that has been implicated in the development and progression of prostate cancer. Oligometastatic castration-sensitive prostate cancer (omCSPC) represents a unique state of disease...